Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism?

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 3, 2008, Pages 794-799

  Lomonte, Carlo ^a   Vernaglione, Luigi ^b   Chimienti, Domenico ^a   Bruno, Andrea ^a   Cocola, Savino ^a   Teutonico, Annalisa ^a   Cazzato, Francesco ^a   Basile, Carlo ^a,c  

^a MIULLI GENERAL HOSPITAL   (Italy)

^b Hospital of Manduria   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; CALCIUM SENSING RECEPTOR; CINACALCET; NAPHTHALENE DERIVATIVE; PHOSPHATE; VITAMIN;

ADULT; AGED; ARTICLE; BODY MASS; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; HYPERPLASIA; MALE; MIDDLE AGED; PARATHYROID GLAND; PARATHYROIDECTOMY; PATHOLOGY; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SEX DIFFERENCE; STATISTICAL MODEL; THYROID PARAFOLLICULAR CELL; TREATMENT FAILURE; UREMIA;

ADULT; AGED; BODY MASS INDEX; CALCITRIOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; LOGISTIC MODELS; MALE; MIDDLE AGED; NAPHTHALENES; OXYPHIL CELLS; PARATHYROID GLANDS; PARATHYROIDECTOMY; PHOSPHATES; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TREATMENT FAILURE; UREMIA; VITAMINS;

EID: 44649151279     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04150907     Document Type: Article

References (20)

1. Rodriguez M, Canalejo A, Garfia B, Aguilera E, Almaden Y: Pathogenesis of refractory secondary hyperparathyroidism. Kidney Int 61: S155-S160, 2002
2. Drüeke T, Martin D, Rodriguez M: Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies. Nephrol Dial Transplant 22: 1828-1839, 2007
3. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 289: F8-F28, 2005
4. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC: Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366: 575-580, 1993
5. Brown EM, Mac Leod RJ: Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81: 239-297, 2001
6. de Francisco AL: Cinacalcet HCl: A novel therapeutic for hyperparathyroidism. Expert Opin Pharmacother 6: 441-452, 2005
7. Lomonte C, Antonelli M, Losurdo N, Marchio G, Giammaria B, Basile C: Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy. Nephrol Dial Transplant 22: 2056-2062, 2007
8. Rodriguez M, Nemeth E, Martin D: The calcium-sensing receptor: A key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol 288: F253-F264, 2005
9. Custódio MR, Montenegro F, Costa AF, dos Reis LM, Buchpiguel CA, Oliveira SG, Noronha IL, Moysés RM, Jorgetti V: MIBI scintigraphy, indicators of cell proliferation and histology of parathyroid glands in uraemic patients. Nephrol Dial Transplant 20: 1898-1903, 2005
10. Basile C, Lomonte C, Vernaglione L, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Cazzato F: A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uremia. Nephrol Dial Transplant 21: 968-974, 2006
11. Lomonte C, Martino R, Selvaggiolo M, Bona RM, Cazzato F, Milano R, Chiarulli G, Basile C: Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients. J Nephrol 16: 716-720, 2003
12. Drüeke TB: Cell biology of parathyroid gland hyperplasia. in chronic renal failure. J Am Soc Nephrol 11: 1141-1152, 2000
13. Szende B, Farid P, Végsõ G, Perner F, Kopper L: Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism. Pathol Oncol Res 10: 98-103, 2004
14. Matsushita H, Hara M, Endo Y, Shishiba Y, Hara S, Ubara Y, Nakazawa H, Suzuki N, Kawaminami K, Kido T, Li Q, Grimelius L: Proliferation of parathyroid cells negatively correlates with expression of parathyroid hormone-related protein in secondary parathyroid hyperplasia. Kidney Int 55: 130-138, 1999
15. Kitazawa R, Kitazawa S, Maeda S, Kobayashi A: Expression of parathyroid hormone-related protein (PTHrP) in parathyroid tissue under normal and pathological conditions. Histol Histopathol 17: 179-184, 2002
16. Mizobuchi M, Ogata H, Hatamura I, Saji F, Koiwa F, Kinugasa E, Koshikawa S, Akizawa T: Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid glands. Biochem Biophys Res Commun 362: 11-16, 2007
17. Almaden Y, Felsenfeld AJ, Rodriguez M, Cañadillas S, Luque F, Bas A, Bravo J, Torregrosa V, Palma A, Ramos B, Sanchez C, Martin-Malo A, Canalejo A: Proliferation in hyperplastic human and normal rat parathyroid glands: Role of phosphate, calcitriol, and gender. Kidney Int 64: 2311-2317, 2003
18. Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F: Parathyroidectomy in patients on renal replacement therapy: An epidemiologic study. J Am Soc Nephrol 12: 1242-1248, 2001
19. Foley RN, Li S, Liu J, Gilbertson DT, Chen S-C, Collins AJ: The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 16: 210-218, 2005
20. Lomonte C, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Antonicelli Verrelli E, Basile C: Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands. J Nephrol 18: 92-95, 2005